Cancer survival rates in Cyprus compared to EU averages

Data presented by Bristol Myers Squibb and the German Oncology Center in Limassol indicates that cancer survival rates in Cyprus exceed the European Union average. Oncologist Dr. Georgios Orfanos presented figures showing survival rates for prostate cancer at 99% in Cyprus versus 87% in the EU, breast cancer at 93% versus 83%, colorectal cancer at 72% versus 60%, and lung cancer at 19% versus 15%. Dr. Orfanos attributed these results to rapid diagnostic responses and modern treatment protocols. Medical Director Dr. Konstantinos Zamboglou emphasized the importance of multidisciplinary teams in providing personalized therapeutic strategies and patient support. Additional presentations by Dr. Eleftherios Vorrias, Dr. Asimina Koulouridi, and Dr. Nana Vassiliadou highlighted advancements in immunotherapy and targeted treatments for various cancers. Dr. Onoufrios Tsavaris noted the significance of standardized therapeutic guidelines in managing patient care.